The trade war amplified calls in the U.S. and elsewhere for reducing dependence on China for strategic goods. Now, the pandemic has politicians vowing to take action.
Christopher Tang, professor at UCLA's Anderson School of Management, describes what it will take for hospital and healthcare supply chains to recover from the COVID-19 pandemic.
The Food and Drug Administration had to walk back testimony by an official at a Senate hearing last week after he downplayed the scale of China’s dominance of the drug supply chain in the U.S.
The Trump administration plans to pump millions of dollars into producing more medications in the U.S. as the coronavirus pandemic heightens longstanding concerns about the fragility of the global drug supply chain.
The coronavirus pandemic has affected virtually every country in the world, but the ability to combat it with essential medicines varies widely. Low- and middle-income countries (LMICs) are finding it especially tough to access medicines, and ensure the safety and quality of those products that are available.
The coronavirus pandemic is bringing about radical changes in global supply chains. But whether companies can draw on the lessons of the present to handle the challenges of future such events is still in question.